Literature DB >> 7631983

Monte Carlo simulations of membrane signal transduction events: effect of receptor blockers on G-protein activation.

P A Mahama1, J J Linderman.   

Abstract

Cells have evolved elaborate strategies for sensing, responding to, and interacting with their environment. In many systems, interaction of cell surface receptors with extracellular ligand can activate cellular signal transduction pathways leading to G-protein activation and calcium mobilization. In BC3H1 smooth muscle-like cells, we find that the speed of calcium mobilization as well as the fraction of cells which mobilize calcium following phenylephrine stimulation is dependent upon receptor occupation. To determine whether receptor inactivation affects calcium mobilization, we use the receptor antagonist prazosin to block a fraction of cell surface receptors prior to phenylephrine stimulation. For cases of equal receptor occupation by agonist, cells with inactivated or blocked receptors show diminished calcium mobilization following phenylephrine stimulation as compared to cells without inactivated receptors. Ligand/receptor binding and two-dimensional diffusion of receptors and G-proteins in the cell membrane are studied using a Monte Carlo model. The model is used to determine if receptor inactivation affects G-protein activation and thus the following signaling events for cases of equal equilibrium receptor occupation by agonist. The model predicts that receptor inactivation by antagonist binding results in lower G-protein activation not only by reducing the number of receptors able to bind agonist but also by restricting the movement of agonist among free receptors. The latter process is important to increasing the access of bound receptors to G-proteins.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7631983     DOI: 10.1007/bf02584430

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   3.934


  23 in total

1.  The encounter coupling model for beta-adrenergic receptor/GTP-binding protein interaction in the S49 cell. Calculation of the encounter frequency.

Authors:  D Stickle; R Barber
Journal:  Biochem Pharmacol       Date:  1992-05-08       Impact factor: 5.858

2.  Two peptides from the alpha 2A-adrenergic receptor alter receptor G protein coupling by distinct mechanisms.

Authors:  H M Dalman; R R Neubig
Journal:  J Biol Chem       Date:  1991-06-15       Impact factor: 5.157

3.  Evidence for the role of epinephrine binding frequency in activation of adenylate cyclase.

Authors:  D Stickle; R Barber
Journal:  Mol Pharmacol       Date:  1989-09       Impact factor: 4.436

4.  Rapid kinetics of alpha 2-adrenergic inhibition of adenylate cyclase. Evidence for a distal rate-limiting step.

Authors:  W J Thomsen; R R Neubig
Journal:  Biochemistry       Date:  1989-10-31       Impact factor: 3.162

5.  Characterization of coexisting alpha 1- and beta 2-adrenergic receptors on a cloned muscle cell line, BC3H-1.

Authors:  R J Hughes; M R Boyle; R D Brown; P Taylor; P A Insel
Journal:  Mol Pharmacol       Date:  1982-09       Impact factor: 4.436

6.  Alpha-1 adrenergic receptor binding and contraction of rat caudal artery.

Authors:  P W Abel; K P Minneman
Journal:  J Pharmacol Exp Ther       Date:  1986-12       Impact factor: 4.030

7.  Analysis of receptor-mediated activation of GTP-binding protein/adenylate cyclase using the encounter coupling model.

Authors:  D Stickle; R Barber
Journal:  Mol Pharmacol       Date:  1993-03       Impact factor: 4.436

8.  Kinetic analysis of histamine release due to covalently linked IgE dimers.

Authors:  M Dembo; A Kagey-Sobotka; L M Lichtenstein; B Goldstein
Journal:  Mol Immunol       Date:  1982-03       Impact factor: 4.407

9.  Alpha 1-adrenergic receptor activation mobilizes cellular Ca2+ in a muscle cell line.

Authors:  R D Brown; K D Berger; P Taylor
Journal:  J Biol Chem       Date:  1984-06-25       Impact factor: 5.157

10.  Aging of rat heart myocytes disrupts muscarinic receptor coupling that leads to inhibition of cAMP accumulation and alters the pathway of muscarinic-stimulated phosphoinositide hydrolysis.

Authors:  E Moscona-Amir; Y I Henis; M Sokolovsky
Journal:  Biochemistry       Date:  1989-08-22       Impact factor: 3.162

View more
  8 in total

1.  Monte Carlo simulations of receptor dynamics: insights into cell signaling.

Authors:  Christopher J Brinkerhoff; Peter J Woolf; Jennifer J Linderman
Journal:  J Mol Histol       Date:  2004-09       Impact factor: 2.611

2.  Mechanisms of B-cell synapse formation predicted by Monte Carlo simulation.

Authors:  Philippos K Tsourkas; Nicole Baumgarth; Scott I Simon; Subhadip Raychaudhuri
Journal:  Biophys J       Date:  2007-03-23       Impact factor: 4.033

3.  Diffusion-limited reactions in G-protein activation: unexpected consequences of antagonist and agonist competition.

Authors:  Christopher J Brinkerhoff; Ji Sun Choi; Jennifer J Linderman
Journal:  J Theor Biol       Date:  2008-01-11       Impact factor: 2.691

4.  Monte Carlo study of single molecule diffusion can elucidate the mechanism of B cell synapse formation.

Authors:  Philippos K Tsourkas; Marjorie L Longo; Subhadip Raychaudhuri
Journal:  Biophys J       Date:  2008-05-02       Impact factor: 4.033

5.  Cell transit analysis of ligand-induced stiffening of polymorphonuclear leukocytes.

Authors:  R Nossal
Journal:  Biophys J       Date:  1998-09       Impact factor: 4.033

6.  Calculation of diffusion-limited kinetics for the reactions in collision coupling and receptor cross-linking.

Authors:  L D Shea; G M Omann; J J Linderman
Journal:  Biophys J       Date:  1997-12       Impact factor: 4.033

7.  Mechanical anchoring strength of L-selectin, beta2 integrins, and CD45 to neutrophil cytoskeleton and membrane.

Authors:  J Y Shao; R M Hochmuth
Journal:  Biophys J       Date:  1999-07       Impact factor: 4.033

8.  Untangling ligand induced activation and desensitization of G-protein-coupled receptors.

Authors:  Peter J Woolf; Jennifer J Linderman
Journal:  Biophys J       Date:  2003-01       Impact factor: 4.033

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.